Early stage IT and Healthcare Investing

MacroGenics

portfoliocompanies

company snapshot

MacroGenics

Founded in 2000, MacroGenics (MGNX) is a biotechnology company headquartered in Rockville, Maryland that focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases. The company's proprietary Fc engineering technology offers ways of improving antibody function, such as enhancing its ability to eliminate cancer cells, cells that contribute to autoimmune disorders, or those infected with certain pathogens. The company is developing first-in-class product candidates from its autoimmunity, oncology and infectious disease portfolios.

website
www.macrogenics.com
Leadership
Follow The Company
Investment Team
Scott Koenig, CEO
Facebook Google+ Twitter Email LinkedIn Share